Hyperparathyroidism-jaw Tumor Syndrome Confirmed by Preoperative Genetic Testing

Intern Med. 2018 Mar 15;57(6):841-844. doi: 10.2169/internalmedicine.9509-17. Epub 2017 Dec 8.

Abstract

We herein report the case of a young woman who was diagnosed with primary hyperparathyroidism and in whom genetic testing confirmed a diagnosis of hyperparathyroidism-jaw tumor syndrome. Familial hyperparathyroidism was suspected based on the patient's young age at the onset of the disease. Thus, genetic testing was performed. It showed a germline mutation in the HRPT2/CDC73 gene and confirmed the diagnosis of hyperparathyroidism-jaw tumor syndrome. Total parathyroidectomy was performed to prevent recurrence. In patients with early-onset hyperparathyroidism, genetic testing should be considered to facilitate the selection of a proper surgical procedure based on the consideration of future life expectancy.

Keywords: HRPT2/CDC73; hyperparathyroidism; hyperparathyroidism-jaw tumor syndrome; younger age.

Publication types

  • Case Reports

MeSH terms

  • Adenoma / genetics*
  • Adenoma / surgery*
  • Adult
  • Female
  • Fibroma / genetics*
  • Fibroma / surgery*
  • Genetic Predisposition to Disease
  • Genetic Testing
  • Germ-Line Mutation
  • Humans
  • Hyperparathyroidism / genetics*
  • Hyperparathyroidism / surgery*
  • Jaw Neoplasms / genetics*
  • Jaw Neoplasms / surgery*
  • Parathyroid Neoplasms / diagnosis*
  • Parathyroid Neoplasms / surgery*
  • Parathyroidectomy / methods
  • Treatment Outcome
  • Tumor Suppressor Proteins / genetics*
  • Young Adult

Substances

  • CDC73 protein, human
  • Tumor Suppressor Proteins

Supplementary concepts

  • Hyperparathyroidism 2